Neurologic sequelae of severe chikungunya infection in the first 6 months of life : a prospective cohort study 24-months post-infection
BACKGROUND: Perinatally chikungunya infected neonates have been reported to have high rates of post-infection neurologic sequelae, mainly cognitive problems. In older children and adults chikungunya does not appear to have sequelae, but data on postnatally infected infants are lacking.
METHODS: We performed a prospective, non-controlled, observational study of infants infected before the age of 6 months with a severe chikungunya infection during the 2014-2015 epidemic in Curaçao, Dutch Antilles. Two years post-infection cognitive and motor - (BSID-III) and social emotional assessments (ITSEA) were performed.
RESULTS: Of twenty-two infected infants, two died and two were lost to follow up. Eighteen children were seen at follow-up and included in the current study. Of these, 13 (72%) had abnormal scores on the BSID-III (cognitive/motor) or ITSEA.
CONCLUSION: In the first study aimed at postnatally infected infants, using an uncontrolled design, we observed a very high percentage of developmental problems. Further studies are needed to assess causality, however until these data are available preventive measure during outbreaks should also include young infants. Those that have been infected in early infancy should receive follow up.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2021 |
---|---|
Erschienen: |
2021 |
Enthalten in: |
Zur Gesamtaufnahme - volume:21 |
---|---|
Enthalten in: |
BMC infectious diseases - 21(2021), 1 vom: 16. Feb., Seite 179 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
van Ewijk, Roelof [VerfasserIn] |
---|
Links: |
---|
Themen: |
Alphavirus infections |
---|
Anmerkungen: |
Date Completed 15.03.2021 Date Revised 30.03.2024 published: Electronic Citation Status MEDLINE |
---|
doi: |
10.1186/s12879-021-05876-4 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM321523393 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM321523393 | ||
003 | DE-627 | ||
005 | 20240331000217.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2021 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1186/s12879-021-05876-4 |2 doi | |
028 | 5 | 2 | |a pubmed24n1357.xml |
035 | |a (DE-627)NLM321523393 | ||
035 | |a (NLM)33593326 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a van Ewijk, Roelof |e verfasserin |4 aut | |
245 | 1 | 0 | |a Neurologic sequelae of severe chikungunya infection in the first 6 months of life |b a prospective cohort study 24-months post-infection |
264 | 1 | |c 2021 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 15.03.2021 | ||
500 | |a Date Revised 30.03.2024 | ||
500 | |a published: Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a BACKGROUND: Perinatally chikungunya infected neonates have been reported to have high rates of post-infection neurologic sequelae, mainly cognitive problems. In older children and adults chikungunya does not appear to have sequelae, but data on postnatally infected infants are lacking | ||
520 | |a METHODS: We performed a prospective, non-controlled, observational study of infants infected before the age of 6 months with a severe chikungunya infection during the 2014-2015 epidemic in Curaçao, Dutch Antilles. Two years post-infection cognitive and motor - (BSID-III) and social emotional assessments (ITSEA) were performed | ||
520 | |a RESULTS: Of twenty-two infected infants, two died and two were lost to follow up. Eighteen children were seen at follow-up and included in the current study. Of these, 13 (72%) had abnormal scores on the BSID-III (cognitive/motor) or ITSEA | ||
520 | |a CONCLUSION: In the first study aimed at postnatally infected infants, using an uncontrolled design, we observed a very high percentage of developmental problems. Further studies are needed to assess causality, however until these data are available preventive measure during outbreaks should also include young infants. Those that have been infected in early infancy should receive follow up | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Alphavirus infections | |
650 | 4 | |a Chikungunya virus | |
650 | 4 | |a Child development | |
650 | 4 | |a Infant | |
650 | 4 | |a Infant, Newborn, diseases | |
650 | 4 | |a Neurologic manifestations | |
700 | 1 | |a Huibers, Minke H W |e verfasserin |4 aut | |
700 | 1 | |a Manshande, Meindert E |e verfasserin |4 aut | |
700 | 1 | |a Ecury-Goossen, Ginette M |e verfasserin |4 aut | |
700 | 1 | |a Duits, Ashley J |e verfasserin |4 aut | |
700 | 1 | |a Calis, Job C |e verfasserin |4 aut | |
700 | 1 | |a van Wassenaer-Leemhuis, Aleid G |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t BMC infectious diseases |d 2001 |g 21(2021), 1 vom: 16. Feb., Seite 179 |w (DE-627)NLM11120089X |x 1471-2334 |7 nnns |
773 | 1 | 8 | |g volume:21 |g year:2021 |g number:1 |g day:16 |g month:02 |g pages:179 |
856 | 4 | 0 | |u http://dx.doi.org/10.1186/s12879-021-05876-4 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 21 |j 2021 |e 1 |b 16 |c 02 |h 179 |